PFBT
CRL icon

Parkside Financial Bank & Trust’s Charles River Laboratories CRL Stock Holding History

Parkside Financial Bank & Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Sell
992
-17
-2% -$3.03K 0.02% 461
2026
Q1 		$174K Buy
1,009
+13
+1% +$2.41K 0.01% 488
2025
Q4 		$199K Sell
996
-184
-16% -$33.4K 0.01% 458
2025
Q3 		$185K Buy
1,180
+139
+13% +$22.1K 0.01% 464
2025
Q2 		$158K Buy
1,041
+33
+3% +$4.4K 0.02% 495
2025
Q1 		$152K Buy
1,008
+93
+10% +$15.6K 0.02% 450
2024
Q4 		$169K Sell
915
-95
-9% -$18.3K 0.02% 422
2024
Q3 		$199K Buy
1,010
+26
+3% +$5.4K 0.03% 368
2024
Q2 		$203K Sell
984
-59
-6% -$13.4K 0.03% 345
2024
Q1 		$283K Buy
1,043
+164
+19% +$39.2K 0.05% 284
2023
Q4 		$208K Buy
879
+118
+16% +$23.2K 0.04% 299
2023
Q3 		$149K Buy
761
+74
+11% +$15.2K 0.03% 316
2023
Q2 		$144K Sell
687
-45
-6% -$8.95K 0.03% 319
2023
Q1 		$148K Buy
732
+96
+15% +$21.8K 0.04% 293
2022
Q4 		$139K Buy
636
+38
+6% +$8.3K 0.04% 299
2022
Q3 		$118K Buy
598
+144
+32% +$31.1K 0.04% 302
2022
Q2 		$98K Sell
454
-15
-3% -$3.67K 0.03% 350
2022
Q1 		$133K Buy
469
+80
+21% +$24.7K 0.04% 291
2021
Q4 		$147K Sell
389
-24
-6% -$9.32K 0.04% 284
2021
Q3 		$171K Buy
413
+11
+3% +$4.57K 0.05% 225
2021
Q2 		$149K Buy
402
+25
+7% +$8.35K 0.04% 250
2021
Q1 		$109K Buy
+377
New +$105K 0.03% 301

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Parkside Financial Bank & Trust's CRL Position: Q2 2026 in Review

Parkside Financial Bank & Trust reduced its Charles River Laboratories (CRL) stake by 1.7% in Q2 2026, selling an estimated $3.03K and leaving 992 shares worth $225K. The position accounts for 0.02% of the portfolio, ranked #461.

Parkside Financial Bank & Trust first reported a position in CRL in Q1 2021 and has held it in 22 quarters since. The position peaked at $283K in Q1 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Parkside Financial Bank & Trust held 992 shares of Charles River Laboratories worth $225K as of Q2 2026.
  • Parkside Financial Bank & Trust sold 17 Charles River Laboratories shares in Q2 2026, an estimated $3.03K.
  • Charles River Laboratories made up 0.02% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #461 holding.
  • Parkside Financial Bank & Trust first reported a position in Charles River Laboratories in Q1 2021 and has held it in 22 quarters since.
  • Parkside Financial Bank & Trust's Charles River Laboratories position peaked at $283K in Q1 2024.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.